Vertex Pharmaceuticals
VRTX
#153
Rank
NZ$246.85 B
Marketcap
NZ$973.64
Share price
-0.16%
Change (1 day)
30.07%
Change (1 year)

EPS for Vertex Pharmaceuticals (VRTX)

EPS in 2023 (TTM): NZ$21.60

According to Vertex Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$30.89. In 2022 the company made an earnings per share (EPS) of NZ$23.14 an increase over its 2021 EPS that were of NZ$16.22.

EPS history for Vertex Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$21.60-6.66%
2022NZ$23.1442.64%
2021NZ$16.22-12.67%
2020NZ$18.57128.01%
2019NZ$8.15-44.54%
2018NZ$14.69670.09%
2017NZ$1.91-327.66%
2016NZ-$0.84-79.65%
2015NZ-$4.12-26.43%
2014NZ-$5.6053.92%
2013NZ-$3.64316.33%
2012NZ-$0.87-545.45%
2011NZ$0.20-102.92%
2010NZ-$6.721.34%
2009NZ-$6.6313.41%
2008NZ-$5.858.61%
2007NZ-$5.3864.13%
2006NZ-$3.28-18.22%
2005NZ-$4.016.13%
2004NZ-$3.78-16.86%
2003NZ-$4.5578.32%
2002NZ-$2.55164.81%
2001NZ-$0.96-21.32%
2000NZ-$1.22-14.21%
1999NZ-$1.4321.21%
1998NZ-$1.1857.14%
1997NZ-$0.75-61.82%
1996NZ-$1.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$11.92-61.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$6.36-79.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ-$5.53-117.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.77-94.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.06-73.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
NZ-$4.30-113.91%๐Ÿ‡บ๐Ÿ‡ธ USA